GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Debt-to-EBITDA

AK Medical Holdings (HKSE:01789) Debt-to-EBITDA : 0.57 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AK Medical Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$39 Mil. AK Medical Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$53 Mil. AK Medical Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$161 Mil. AK Medical Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.57.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AK Medical Holdings's Debt-to-EBITDA or its related term are showing as below:

HKSE:01789' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01   Med: 0.09   Max: 0.36
Current: 0.36

During the past 10 years, the highest Debt-to-EBITDA Ratio of AK Medical Holdings was 0.36. The lowest was 0.01. And the median was 0.09.

HKSE:01789's Debt-to-EBITDA is ranked better than
76.62% of 432 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs HKSE:01789: 0.36

AK Medical Holdings Debt-to-EBITDA Historical Data

The historical data trend for AK Medical Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings Debt-to-EBITDA Chart

AK Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.06 0.23 0.12 0.26

AK Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.95 0.15 0.21 0.23 0.57

Competitive Comparison of AK Medical Holdings's Debt-to-EBITDA

For the Medical Devices subindustry, AK Medical Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AK Medical Holdings's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's Debt-to-EBITDA falls into.



AK Medical Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AK Medical Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(38.975 + 53.125) / 353.666
=0.26

AK Medical Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(38.975 + 53.125) / 160.9
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


AK Medical Holdings  (HKSE:01789) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


AK Medical Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AK Medical Holdings (HKSE:01789) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200
AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines